Olympus Corporation (”Olympus” – Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has exercised its call option in respect of the remainder of the shares in Medi-Tate Ltd. (“Medi-Tate”, an Israeli medical device company, CEO: Ido Kilemnik). The potential acquisition would further strengthen Olympus’ Therapeutic Solutions Division, a key pillar in its future growth strategy, and solidify its position as a leader in the field of urological devices.
Read moreNews
26/02/21 | Press Release | Medical Systems
Olympus Exercises Option to Buy Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth
Olympus in social media
Exciting stories, interesting insights and the latest product news: Explore more about Olympus on Facebook, Twitter & Co. Our global website offers an overview of our numerous social media profiles worldwide.
Find out more